Abstract
ObjectiveTo compare the benefits and harms of drug treatments for adults with type 2 diabetes, adding non-steroidal mineralocorticoid receptor antagonists (including finerenone) and tirzepatide (a dual glucose dependent insulinotropic polypeptide...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have